Olaplex extends Cosway manufacturing pact to Aug 15; shareholders elect directors, approve auditor

On June 28, 2023, Olaplex, Inc. (“Olaplex”) and Cosway Company Inc. (“Cosway”) entered into an amendment (the “Amendment”) to the Letter Agreement, dated February 22, 2023, between Olaplex and Cosway (the “Letter Agreement”), to further extend the expiration date of the Manufacturing Services Agreement, dated January 1, 2020, by and between Olaplex and Cosway, to August 15, 2023 to allow sufficient time to facilitate the negotiation of a new agreement.

Proposal 1 – Election of Directors Each of the four nominees listed below were elected as Class II directors at the Annual Meeting to serve on the Company’s Board of Directors (the "Board") for a term of three years expiring at the Company’s 2026 Annual Meeting of Stockholders, based on the following votes: For Withheld Broker Non-Votes Janet Gurwitch 575,798,015 27,739,956 4,788,269 Martha Morfitt 602,490,616 1,047,355 4,788,269 David Mussafer 581,261,746 22,276,225 4,788,269 Emily White 582,461,761 21,076,210 4,788,269

Proposal 3 – Ratification of Appointment of Independent Registered Public Accounting Firm The stockholders ratified the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2023, based on the following votes: For Against Abstained 607,800,092 52,281 473,867

Proposal 2 – Advisory Vote on the Frequency of Future Advisory Votes on Named Executive Officer Compensation The stockholders voted on a non-binding advisory basis on the frequency of future non-binding advisory votes on the compensation of the Company’s named executive officers (“Say-on-Frequency”) as follows: 1 Year 2 Years 3 Years Abstained Broker Non-Votes 602,320,947 354,108 706,571 156,345 4,788,269